基于3D打印的贝的输送系统:一种生物聚合物平台,用于肠道向生物活性化合物
Siraprapa Chansatidkosol1, Chutima Limmatvapirat2,3, Pornsak Sriamornsak2
1Faculty of Pharmaceutical Sciences, Burapha University, Chonburi 20131, Thailand.
ACS omega
|October 27, 2025
概括
3D打印的贝设备提供精确的肠道输送. 较厚的设计增强机械强度和控制药物释放,保护敏感化合物免受胃酸的影响.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
背景情况:
- 特定地点的药物输送仍然是一个挑战.
- 自然聚合物为药物封装提供生物相容平台.
- 3D打印使复杂的设备几何结构可用于受控释放.
研究的目的:
- 开发和表征3D打印的贝基设备,用于有针对性的肠道输送.
- 调查结构参数对设备性能的影响.
- 从这些设备中评估模型药物的释放动力学.
主要方法:
- 化沉积建模 (FDM) 3D打印使用贝和聚乙烯甘醇) 10000 (PEG 10000).
- 基础和侧壁厚度的系统变化.
- 使用扫描电子显微镜 (SEM),机械测试和热分析进行表征.
- 在体外分解和溶解测试用甲醇化物.
主要成果:
- 成功制造出具有一致形态和强大的机械性能的贝设备.
- 增加设备厚度显著提高了机械强度.
- 较厚的设备在模拟的肠液中表现出对酸性条件的耐药性和受控释放.
- 甲醇化的释放是由结构参数调节的.
结论:
- 基于贝的3D打印设备是一个多功能平台,用于特定站点的肠道输送.
- 设备厚度是控制机械完整性和药物释放配置文件的关键参数.
- 这些平台适合提供需要胃保护的药物,宏分子,益生菌和营养药物.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
Bioavailability Enhancement: Drug Permeability Enhancement
183
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
183
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
493
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
493


